LUGPA 2024 Enduring CME Program: Emerging Technologies to Advance Urologic Care in 2025-LUGPA 2024 CME Program Part 2

Video Transcription

Video Summary

Dr. Arvind George, an expert in urology particularly in prostate cancer management, discusses focal therapies and their growing significance in treating prostate cancer. Emphasizing patient selection, Dr. George outlines that the success of focal therapies depends on choosing the right patients, energy source, and treatment template. He notes that while focal therapy aims for cancer control rather than a complete cure, it can significantly delay treatment recurrence. Functional outcomes are highlighted as markedly superior to radical treatments. Dr. George supports the use of focal therapy particularly in salvage settings and post-radiation failures, and stresses the importance of patient-specific strategies, including the management of intermediate to high-risk prostate cancer cases.<br /><br />In a subsequent segment, Dr. Rani Abaza discusses innovations in robotic surgery, including new robotic systems like the DaVinci 5, which features haptic feedback and improved computing power. The presentation underscores the integration of AI and augmented reality in robotic surgery, aiming for more precise and efficient procedures.<br /><br />Overall, the presentations focus on innovations in urology, emphasizing the importance of personalized treatment plans, technological advancements, and the potential of less invasive procedures providing effective cancer control while preserving patient quality of life.

Keywords

urology

prostate cancer

focal therapies

robotic surgery

patient selection

DaVinci 5

AI in surgery

augmented reality

personalized treatment